Northpond Ventures GP, LLC - Sep 17, 2021 Form 4 Insider Report for DICE Therapeutics, Inc. (DICE)

Role
10%+ Owner
Signature
Northpond Ventures GP, LLC, By: /s/ Patrick Smerkers, Senior Vice President, Finance and Operations
Stock symbol
DICE
Transactions as of
Sep 17, 2021
Transactions value $
$3,995,000
Form type
4
Date filed
9/20/2021, 09:19 PM
Previous filing
Sep 14, 2021
Next filing
Jan 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction DICE Common Stock +Conversion of derivative security +2,603,075 2,603,075 Sep 17, 2021 By: Northpond Ventures, LP F1, F3
transaction DICE Common Stock +Conversion of derivative security +454,796 +17.47% 3,057,871 Sep 17, 2021 By: Northpond Ventures II, LP F2, F4
transaction DICE Common Stock +Buy $3,995,000 +235,000 +7.69% $17.00 3,292,871 Sep 17, 2021 By: Northpond Ventures II, LP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Series B Convertible Preferred Stock -Conversion of derivative security -1,735,388 -100% 0 Sep 17, 2021 Common Stock 1,735,388 By: Northpond Ventures, LP F1, F3
transaction DICE Series C Convertible Preferred Stock -Conversion of derivative security -867,687 -100% 0 Sep 17, 2021 Common Stock 867,687 By: Northpond Ventures, LP F1, F3
transaction DICE Series C-1 Convertible Preferred Stock -Conversion of derivative security -454,796 -100% 0 Sep 17, 2021 Common Stock 454,796 By: Northpond Ventures II, LP F2, F4

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the initial public offering of DICE Therapeutics, Inc. (the "Issuer"), each share of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Convertible Preferred Stock"), of the Issuer and each share of Series C Convertible Preferred stock, par value $0.0001 per share of the Issuer (the "Series C Convertible Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). The right to convert the Series B Convertible Preferred Stock and Series C Preferred Stock into Common Stock had no expiration date.
F2 Immediately prior to the closing of the initial public offering of the Issuer, each share of Series C-1 Convertible Preferred Stock, par value $0.0001 per share (the "Series C-1 Convertible Preferred Stock"), of the Issuer automatically converted on a one-for-one basis into shares of the Issuer's Common Stock. The right to convert the Series C-1 Convertible Preferred Stock had no expiration date.
F3 Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F4 Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.